TsAP-2 (T. serrulatus antimicrobial peptide 2)

General Information


DRACP ID  DRACP00466

Peptide Name   TsAP-2 (T. serrulatus antimicrobial peptide 2)

Sequence  FLGMIPGLIGGLISAFK

Sequence Length  17

UniProt ID  S6D3A7  Q5G8B5 

PubChem CID  Not available

Origin  Tityus serrulatus (Brazilian yellow scorpion)

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
NCI-H157 Lung squamous cell carcinoma Carcinoma IC50=4.1μM MTT assay 24h 1
NCI-H838 Lung adenocarcinoma Carcinoma IC50=11.0μM MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=6.4μM MTT assay 24h 1
PC-3 Prostate carcinoma Carcinoma IC50=13.3μM MTT assay 24h 1
U-251MG Astrocytoma Carcinoma IC50=15.4μM MTT assay 24h 1

Hemolytic Activity  Horse erythrocytes(possess little haemolytic activity (6.48%) at the highest concentration tested (160 μM) )

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticance; Antimicrobial; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00466

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C84H136N18O19S

Absent amino acids  CDEHNQRTVWY

Common amino acids  G

Mass  201976

Pl  9.7

Basic residues  1

Acidic residues  0

Hydrophobic residues  9

Net charge  1

Boman Index  3445

Hydrophobicity  154.71

Aliphatic Index  143.53

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23770440

Title  Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities

Doi 10.1016/j.biochi.2013.06.003

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.